{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T20:19:34Z","timestamp":1722716374768},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,12,8]]},"DOI":"10.18632\/oncotarget.5974","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T12:59:15Z","timestamp":1446641955000},"page":"42053-42066","source":"Crossref","is-referenced-by-count":14,"title":["MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data"],"prefix":"10.18632","volume":"6","author":[{"given":"Giulia","family":"Pasello","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Medical Oncology 2, Istituto Oncologico Veneto IRCCS Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Urso","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manlio","family":"Mencoboni","sequence":"additional","affiliation":[{"name":"Oncology Unit, Villa Scassi Hospital, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Grosso","sequence":"additional","affiliation":[{"name":"Oncohematologic Department, Mesothelioma Unit, Oncology, SS Antonio e Biagio General Hospital, Alessandria, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Luca","family":"Ceresoli","sequence":"additional","affiliation":[{"name":"Oncology, Cliniche Humanitas Gavazzeni, Bergamo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Lunardi","sequence":"additional","affiliation":[{"name":"Department of Cardio-Thoracic and Vascular Sciences, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania Edith","family":"Vuljan","sequence":"additional","affiliation":[{"name":"Department of Cardio-Thoracic and Vascular Sciences, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Bertorelle","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IRCCS, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Sacchetto","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IRCCS, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Ciminale","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy"},{"name":"Department of Clinical and Experimental Oncology, Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IRCCS, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Rea","sequence":"additional","affiliation":[{"name":"Department of Cardio-Thoracic and Vascular Sciences, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Favaretto","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Medical Oncology 2, Istituto Oncologico Veneto IRCCS Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PierFranco","family":"Conte","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Medical Oncology 2, Istituto Oncologico Veneto IRCCS Padova, Italy"},{"name":"Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorella","family":"Calabrese","sequence":"additional","affiliation":[{"name":"Department of Cardio-Thoracic and Vascular Sciences, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,30]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","article-title":"Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada","volume":"23","author":"Giaccone","year":"2005","journal-title":"Journal of clinical oncology official journal of the American Society of Clinical Oncology"},{"key":"2","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Paoletti","year":"2003","journal-title":"Journal of clinical oncology official journal of the American Society of Clinical Oncology"},{"key":"3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2012.03.001","article-title":"An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma","volume":"39","author":"Favaretto","year":"2013","journal-title":"Cancer treatment reviews"},{"key":"4","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/cncr.23337","article-title":"Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma","volume":"112","author":"Santoro","year":"2008","journal-title":"Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1745-6673-3-34","article-title":"Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study","volume":"3","author":"Serke","year":"2008","journal-title":"Journal of occupational medicine and toxicology"},{"key":"6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.lungcan.2011.01.005","article-title":"Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience","volume":"73","author":"Favaretto","year":"2011","journal-title":"Lung cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2010.12.004","article-title":"Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma","volume":"72","author":"Santoro","year":"2011","journal-title":"Lung cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2174\/138945009789753200","article-title":"Molecular targets in malignant pleural mesothelioma treatment","volume":"10","author":"Favaretto","year":"2009","journal-title":"Current drug targets"},{"key":"9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/cgt.2013.1","article-title":"Gene therapy for malignant mesothelioma: current prospects and challenges","volume":"20","author":"Hiroshima","year":"2013","journal-title":"Cancer gene therapy"},{"key":"10","first-page":"993","article-title":"MDM2, an introduction","volume":"1","author":"Lozano","year":"2003","journal-title":"Molecular cancer research MCR"},{"key":"11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s10147-013-0639-1","article-title":"Subcellular localization of Mdm2 expression and prognosis of breast cancer","volume":"19","author":"Park","year":"2014","journal-title":"International journal of clinical oncology"},{"key":"12","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0092-8674(92)90644-R","article-title":"The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation","volume":"69","author":"Levine","year":"1992","journal-title":"Cell"},{"key":"13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Levine","year":"2000","journal-title":"Nature"},{"key":"14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","article-title":"MDM2, MDMX and p53 in oncogenesis and cancer therapy","volume":"13","author":"Wahl","year":"2013","journal-title":"Nature reviews Cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2174\/09298673113206660325","article-title":"Targeting MDM2-p53 interaction for cancer therapy: are we there yet?","volume":"21","author":"Zhang","year":"2014","journal-title":"Current medicinal chemistry"},{"key":"16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/1541-7786.MCR-14-0089","article-title":"Therapeutic efficacy of p53 restoration in Mdm2-overexpressing tumors","volume":"12","author":"Lozano","year":"2014","journal-title":"Molecular cancer research MCR"},{"key":"17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1593\/neo.06148","article-title":"p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma","volume":"8","author":"Stahel","year":"2006","journal-title":"Neoplasia"},{"key":"18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1165\/ajrcmb.16.1.8998073","article-title":"Absence of p53 mutations in malignant mesotheliomas","volume":"16","author":"Reichert","year":"1997","journal-title":"American journal of respiratory cell and molecular biology"},{"key":"19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/bjc.2015.27","article-title":"MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14\/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53","volume":"112","author":"Wohlschlaeger","year":"2015","journal-title":"British journal of cancer"},{"key":"20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.lungcan.2005.07.010","article-title":"Expression and prognostic significance of hypoxia-inducible factor 1alpha (HIF-1alpha) in malignant pleural mesothelioma (MPM)","volume":"51","author":"Fennell","year":"2006","journal-title":"Lung cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1378\/chest.128.5.3382","article-title":"Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma","volume":"128","author":"Caglar","year":"2005","journal-title":"Chest"},{"key":"22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.bjc.6690650","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours","volume":"81","author":"Pass","year":"1999","journal-title":"British journal of cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1158\/0008-5472.CAN-06-4738","article-title":"Regulation of angiogenic factors by HDM2 in renal cell carcinoma","volume":"68","author":"Ashcroft","year":"2008","journal-title":"Cancer research"},{"key":"24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1158\/0008-5472.CAN-06-2710","article-title":"Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2","volume":"67","author":"Mayo","year":"2007","journal-title":"Cancer research"},{"key":"25","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/cncr.22552","article-title":"Update on the molecular biology of malignant mesothelioma","volume":"109","author":"Jablons","year":"2007","journal-title":"Cancer"},{"key":"26","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/JTO.0000000000000198","article-title":"Synergistic antitumor activity of recombinant human Apo2L\/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma","volume":"9","author":"Favaretto","year":"2014","journal-title":"Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-12-2807","article-title":"MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models","volume":"73","author":"Vassilev","year":"2013","journal-title":"Cancer research"},{"key":"28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.molonc.2014.08.005","article-title":"The p53\/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours","volume":"9","author":"Hanemann","year":"2015","journal-title":"Molecular oncology"},{"key":"29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2217\/fon.13.261","article-title":"Mdm2 protein expression is strongly associated with survival in malignant pleural mesothelioma","volume":"10","author":"Wohlschlaeger","year":"2014","journal-title":"Future oncology"},{"key":"30","article-title":"MDM2\u2032s social network","author":"Olivares-Illana","year":"2013","journal-title":"Oncogene"},{"key":"31","doi-asserted-by":"crossref","first-page":"15608","DOI":"10.1073\/pnas.95.26.15608","article-title":"Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis","volume":"95","author":"Bradley","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"32","first-page":"794","article-title":"Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas","volume":"54","author":"Levine","year":"1994","journal-title":"Cancer research"},{"key":"33","first-page":"171","article-title":"Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods","volume":"8","author":"Cordon-Cardo","year":"2002","journal-title":"Clinical cancer research an official journal of the American Association for Cancer Research"},{"key":"34","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1101\/gad.11.6.714","article-title":"Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53","volume":"11","author":"Finlay","year":"1997","journal-title":"Genes & development"},{"key":"35","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1158\/0008-5472.CAN-08-3732","article-title":"Mdm2 affects genome stability independent of p53","volume":"69","author":"Eischen","year":"2009","journal-title":"Cancer research"},{"key":"36","article-title":"Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study","author":"Scagliotti","year":"2014","journal-title":"Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer"},{"key":"37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1541-7786.1.2.1","article-title":"MDM and prognosis","volume":"2","author":"Cordon-Cardo","year":"2004","journal-title":"Molecular cancer research MCR"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T04:31:45Z","timestamp":1653453105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,30]]},"references-count":37,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2015,12,8]]}},"alternative-id":["5974","26544728"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5974","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,30]]}}}